Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis
Ting Wen, … , Daniel Douek, Marc E. Rothenberg
Ting Wen, … , Daniel Douek, Marc E. Rothenberg
Published April 8, 2019
Citation Information: J Clin Invest. 2019;129(5):2014-2028. https://doi.org/10.1172/JCI125917.
View: Text | PDF
Research Article Immunology

Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis

  • Text
  • PDF
Abstract

T cell heterogeneity is highly relevant to allergic disorders. We resolved the heterogeneity of human tissue CD3+ T cells during allergic inflammation, focusing on a tissue-specific allergic disease, eosinophilic esophagitis (EoE). We investigated 1088 single T cells derived from patients with a spectrum of disease activity. Eight disparate tissue T cell subtypes (designated T1–T8) were identified, with T7 and T8 enriched in the diseased tissue. The phenotypes of T7 and T8 resemble putative Treg (FOXP3+) and effector Th2-like (GATA3+) cells, respectively. Prodigious levels of IL-5 and IL-13 were confined to HPGDS+ CRTH2+IL-17RB+FFAR3+CD4+ T8 effector Th2 cells. EoE severity closely paralleled a lipid/fatty acid–induced activation node highlighted by the expression of the short-chain fatty acid receptor FFAR3. Ligands for FFAR3 induced Th2 cytokine production from human and murine T cells, including in an in vivo allergy model. Therefore, we elucidated the defining characteristics of tissue-residing CD3+ T cells in EoE, a specific enrichment of CD4+ Treg and effector Th2 cells, confinement of type 2 cytokine production to the CD4+ effector population, a highly likely role for FFAR3 in amplifying local Th2 responses in EoE, and a resource to further dissect tissue lymphocytes and allergic responses.

Authors

Ting Wen, Bruce J. Aronow, Yrina Rochman, Mark Rochman, Kiran KC, Phil J. Dexheimer, Philip Putnam, Vincent Mukkada, Heather Foote, Kira Rehn, Sam Darko, Daniel Douek, Marc E. Rothenberg

×

Figure 2

FACS analysis of CD3+ T cells in blood and tissue.

Options: View larger image (or click on image) Download as PowerPoint
FACS analysis of CD3+ T cells in blood and tissue.
(A) The number of CD4...
(A) The number of CD4+, CD8+, and pan CD3+ T cells isolated from a single biopsy were enumerated from 4 different cohorts: normal (N, n = 9), complete remission (CR, n = 6), partial remission (PR, n = 12), and active inflammation (A, n = 13). Two-way ANOVA, EoE factor: P < 0.001; CD4/CD8 factor: P < 0.001; interaction, nonsignificant. (B) With the same 4 disease cohorts, the CD4/CD8 ratio was quantified from autologous blood and tissue samples. Two-way ANOVA, EoE factor nonsignificant; tissue/blood factor: P < 0.001; interaction, nonsignificant. (C) The percentages of CD25+ events were quantified by normalizing to gated CD4+ or CD8+ events. CD25+/CD4+ 2-way ANOVA, EoE factor: P < 0.001; tissue/blood factor: P < 0.001; interaction, P < 0.01. Bonferroni test: P < 0.05, normal controls (N) versus PR; P < 0.001, N versus A. (D) The percentage of CD25+CD4+ cells was correlated with tissue eosinophilia, but not autologous blood eosinophilia, with the P value and Spearman r shown. (E) Tissue and autologous blood CD3+CD4+ events (blue) plotted in the context of multiple proteins of interest, with CD25+ events labelled in red. Two-way ANOVA was used for multi-comparisons in C, D and E. Box and whisker plots are shown indicating mean and minimum/maximum values.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts